x

Rechercher un essai clinique

* (*) Champ obligatoire

40 Résultat(s)

Essai en cours de recrutement = Essai en cours de recrutement; Essai en cours = Essai en cours; Financé par un membre IRDiRC =

Essai(s) clinique(s) national(aux)

ALLEMAGNE

Berlin
BERLIN

Essai en coursCSOM230D2203: An open label, multicentre, single arm phase II study of Pasireotide LAR in patients with Rare Tumors of Neuroendocrine Origin - DE
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik für Endokrinologie und Stoffwechselmedizin (einschl. Arbeitsbereich Lipidstoffwechsel)

ESPAGNE

País Vasco
BARAKALDO

A Multicenter, Randomized, Blinded Study to Assess Safety and Efficacy of Pasireotide LAR vs. Octreotide LAR in Patients With Active Acromegaly (Phase III) - ES (Completed)
Hospital Universitario Cruces - Osakidetza
Investigación en Genética y Control de Diabetes y Enfermedades Endocrinas

GRECE

ATTIKI
ATHENS

A study to compare the efficacy and PEGA-0435 safety of Pegvisomant to that of sandostatin LAR in patients with acromegaly (Phase IV)
Evangelismos general hospital
Hormonal laboratory (Director Prof. Nikolaos Thalassinos)

GRECE

ATTIKI
ATHENS

Observational study in patients with acromegaly on octreotide treatment
Evangelismos general hospital
Hormonal laboratory (Director Prof. Nikolaos Thalassinos)

ROYAUME-UNI

Greater Manchester
NOT YET IDENTIFIED - UK

Essai(s) clinique(s) multinational(aux)